Nanalysis Scientific Corp (OTCPK:NSCIF)
$ 0.088 (0%) Market Cap: 12.35 Mil Enterprise Value: 22.44 Mil PE Ratio: 0 PB Ratio: 1.33 GF Score: 47/100

Q1 2025 Nanalysis Scientific Corp Earnings Call Transcript

May 28, 2025 / 09:00PM GMT
Release Date Price: $0.205

Key Points

Positve
  • Nanalysis Scientific Corp (NSCIF) achieved a significant improvement in gross margin percentage for product sales, increasing from 47% to 66% year-over-year.
  • The company reported a positive adjusted EBITDA of $180,000 for Q1 2025, compared to a loss of $104,000 in the same period last year.
  • Net loss improved by $1.2 million year-over-year, attributed to better product sales margins and cost reduction measures.
  • The company successfully launched its next-generation 60 megahertz technology, which has over twice the performance of the previous generation.
  • Nanalysis Scientific Corp (NSCIF) negotiated a favorable renewal of its term loan, including a 12-month reduction in principal payments and company-friendly covenant testing.
Negative
  • Consolidated revenue decreased by 5% compared to the same period in 2024, falling short of expectations.
  • Security Service gross margin percentage declined from 8% to 6% due to higher service costs, including overtime wages.
  • Revenue from third-party equipment sales remains a significant part of the company's revenue, indicating a reliance on selling other companies' technologies.
  • The company experienced a softening of revenue in Q1 2025 due to macroeconomic uncertainties, particularly in the United States.
  • Certain expected orders from major customers like the FDA and EPA were delayed, impacting revenue growth.
Operator

Good afternoon, ladies and gentlemen, and welcome to the Nanalysis Scientific Q1 2025 conference call. (Operator Instructions) This call is being recorded on Wednesday, May 28, 2025. And I would now like to turn the conference over to Mr. Matthew Selinger, Investor Relations. Please go ahead.

Matthew Selinger
Nanalysis Scientific Corp - Investor Relations Manager

Thank you, operator, and welcome, everyone, to Nanalysis Scientific's first quarter 2025 conference call. Before we begin, I would like to remind everyone that our remarks and responses to your questions today will contain forward-looking statements that are based on the current expectations of management. These assumptions involve inherent risks and uncertainties that could cause actual results to differ materially from our responses. Certain material factors and assumptions were considered and applied in making the forward-looking statements. These risk factors are included in our filings for the year ended December 31, 2024.

Forward-looking statements on this call may include, but are not

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot